»    »  Brazil Pharmaceuticals and Healthcare Report

Brazil Pharmaceuticals and Healthcare Report

Published OnOct, 2016
Pages107
License 
FormatPDF
Cement: 2014 Market Review and Forecast
Buy through us and save. We do not add any Tax / Duty including VAT,GST
The Brazil Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Brazil Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Brazil pharmaceutical and healthcare industry.

Key Benefits

-Benchmark BMI's pharmaceutical and healthcare market forecasts for Brazil, to test other views - a key input for successful budgeting and strategic business planning in the Brazilian pharmaceutical and healthcare market.
-Target business opportunities and risks in the Brazilian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Brazil.
- Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View

An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT outlines strategic factors that affect the basic assum
BMI Industry View . 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Brazil 2014-2020)            . . . . . 7
SWOT  10
Industry Forecast  12
Pharmaceutical Market Forecast .. 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Brazil 2012-2020)            . . 14
Healthcare Market Forecast ........ 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020)          . . . 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020)        . . 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020)         . 18
Prescription Drug Market Forecast ........ 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020)         . . . . 20
Patented Drug Market Forecast ... 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020)          . 22
Generic Drug Market Forecast .... 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020)          . . 25
OTC Medicine Market Forecast ... 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Brazil 2012-2020)      . . . 27
Pharmaceutical Trade Forecast ... 28
Table: Pharmaceutical Trade Data And Forecasts (Brazil 2014-2020)              . 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Brazil 2014-2020)           . . . 31
Industry Risk/Reward Index ... 32
Americas Risk/Reward Index ....... 32
Brazil Risk/Reward Index .. 39
Rewards ... 39
Risks ........ 39
Regulatory Review ........ 41
Intellectual Property Issues ........ 42
Pricing Regime .... 45
Reimbursement Regime ... 46
Market Overview . 49
Healthcare Sector  49
Table: Healthcare Resources (Brazil 2010-2015)                  50
Table: Healthcare Personnel (Brazil 2010-2015)                  50
Table: Healthcare Activity (Brazil 2010-2015)                  . . . 51
Research & Development  51
Biotechnology ..... 53
Clinical Trials ..... 54
Epidemiology ...... 55
Competitive Landscape  58
Research-Based Industry . 58
Table: Top 10 Pharmaceutical Companies In Brazil By Sales In 2013              . 58
Table: Multinational Pharmaceutical Company Activity                . . . . . 59
Generic Drugmakers ...... 59
Pharmaceutical Distribution ...... 62
Pharmaceutical Retail Sector ..... 64
Company Profile .. 66
Aché/Biosintética ... 66
Cristália .... 69
EMS Sigma . 72
Eurofarma .. 75
GlaxoSmithKline ... 77
Medley ...... 80
Merck & Co  82
Novartis ..... 84
Pfizer ........ 87
Roche ........ 90
Sanofi ........ 93
Demographic Forecast . 96
Table: Population Headline Indicators (Brazil 1990-2025)                . . 97
Table: Key Population Ratios (Brazil 1990-2025)                 . . . . . 97
Table: Urban/Rural Population & Life Expectancy (Brazil 1990-2025)              . 98
Table: Population By Age Group (Brazil 1990-2025)                 . . 98
Table: Population By Age Group % (Brazil 1990-2025)                . . . . . 99
Glossary ... 101
Methodology ...... 103
Pharmaceutical Expenditure Forecast Model .. 103
Healthcare Expenditure Forecast Model ......... 103
Notes On Methodology .. 104
Risk/Reward Index Methodology ......... 105
Index Overview .. 106
Table: Pharmaceutical Risk/Reward Index Indicators                 106
Indicator Weightings .... 107
Brazil Insurance Report
BMI View: Brazil's insurance industry has continued to grow despite the combined effects of low economic growth and high inflation on the country's wider financial services sector. The core drivers of growth over recent years have been the expansion of the middle class, combined with an ageing population which, together, have supported
Brazil Real Estate Report

View: Brazil's sluggish economic growth, forecasted at 2.8% for 2014, continues to dampen both investor and consumer confidence and weakens its economic position in Latin America. As the host of major sporting events in 2014 and 2016, economists were hopeful about the potential growth opportunities that this would bring. However, industrial prod

Brazil Food and Drink Report
BMI View: The Brazilian consumer faces a dim outlook over 2016, on the back of a deepening recession. A weak economic environment characterised by slow job creation and high inflation will continue to constrain private consumption growth. As a result the food and drink industry will contract in US dollar terms over 2016. Key Trends &
Brazil Retail Report
BMI View: Brazil is in the midst of the largest economic and political crisis in more than a decade. This is having an adverse impact on household incomes and consumer confidence. While a gradual recovery is expected to start in 2017, a weak labour market, elevated inflation and reduced access to consumer credit will continue weighing o
Purified Terephthalic Acid (PTA) Industry Outlook in Brazil to 2019 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Purified Terephthalic Acid (PTA) Industry Outlook in Brazil to 2019 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants, provides in-depth coverage of Brazil’s Purified Terephthalic Acid (PTA) industry and presents major market trends.

Enquiry Form

Please fill out the form. Our executive will get back to you within 24 hours.

Name *
Email *
Phone *
Company *
Designation *
Enquire AboutBrazil Pharmaceuticals and Healthcare Report
Message
captcha code
Note: * Denotes Required Fields.

Contact Us


Market Reports on Brazil


808, Real Tech Park,
8th Floor, Sector - 30A,
Vashi, Navi Mumbai - 400703, India.

India: +91 22 27810772, 27810773
Email: info@marketreportsonbrazil.com

Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Custom Research

If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice.
Please visit Custom Research page to make an enquiry.